Source:http://linkedlifedata.com/resource/pubmed/id/11747152
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2001-12-17
|
pubmed:abstractText |
Acute side-branch (SB) compromise or occlusion stent jail after native coronary stenting is a matter of concern. Attempts at maintaining SB patency can be a technical challenge. The purpose of this study was to determine the clinical impact of SB compromise or occlusion in patients undergoing stenting of parent vessel lesions. We evaluated in-hospital and long-term clinical outcomes (death, Q-wave myocardial infarction, and repeat revascularization rates at 6 months) in 318 consecutive patients undergoing NIR stent implantation across an SB. Based on independent angiographic analysis, 218 (68.6%) patients had no poststent SB compromise, 85 (26.7%) patients had narrowed SB (> 70% narrowing, without total occlusion), and 15 (4.7%) patients had an occluded SB after stent implantation. The baseline patient and lesion characteristics were similar between the groups. Procedural success was 100%. Patients with SB occlusion had a higher stents/lesion ratio (P < 0.006). Side-branch occlusion was associated with higher in-hospital ischemic complications (Q-wave myocardial infarction, 7%; non-Q-wave myocardial infarction, 20%; P < 0.05) compared to patients with SB compromise or normal SB. At 6-month follow-up, there was a trend for more myocardial infarctions in the group with SB occlusion during the index procedure (Q-wave myocardial infarction, 7% vs. 1% in the narrowed and 0% in normal SB; P = 0.09). However, late target lesion revascularization and mortality were similar in the three groups (P = 0.91). SB occlusion after parent vessel stenting is associated with more frequent in-hospital Q-wave and non-Q-wave myocardial infarctions. However, with the NIR stent, side-branch compromise or occlusion does not influence late (6 month) major adverse events, including death, myocardial infarction, or need for repeat revascularization.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1522-1946
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2001 Wiley-Liss, Inc.
|
pubmed:issnType |
Print
|
pubmed:volume |
54
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
295-300
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11747152-Aged,
pubmed-meshheading:11747152-Coronary Angiography,
pubmed-meshheading:11747152-Coronary Artery Bypass,
pubmed-meshheading:11747152-Coronary Stenosis,
pubmed-meshheading:11747152-Female,
pubmed-meshheading:11747152-Follow-Up Studies,
pubmed-meshheading:11747152-Graft Occlusion, Vascular,
pubmed-meshheading:11747152-Humans,
pubmed-meshheading:11747152-Male,
pubmed-meshheading:11747152-Middle Aged,
pubmed-meshheading:11747152-Stents,
pubmed-meshheading:11747152-Time,
pubmed-meshheading:11747152-Treatment Outcome
|
pubmed:year |
2001
|
pubmed:articleTitle |
Clinical outcomes of compromised side branch (stent jail) after coronary stenting with the NIR stent.
|
pubmed:affiliation |
Cardiac Catheterization Laboratory, Division of Cardiology, Washington Hospital Center, Washington, DC, USA. bbhargava@visto.com
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|